🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,254 results for “First” Clear

  1. Paclitaxel, Cisplatin Plus 5-FU (TCF)

    First Tracks Biotherapeutics

    Esophageal Cancer Stage IIB

    phase 3 other active

    1 trial

  2. Pembrolizumab

    First Tracks Biotherapeutics

    Esophageal Squamous Cell Carcinoma

    phase 3 mab active

    1 trial

  3. Preoperative hepatic and regional arterial chemotherapy using oxaliplatin, MMC and FUDR

    First Tracks Biotherapeutics

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  4. Qarziba 4.5 mg/mL concentrate for solution for infusion

    COLLEGIUM PHARMACEUTICAL, INC

    Recurrent or progression of neuroblastoma or neuroblastoma or neuroblastoma refractory to first-line treatment.

    phase 3 small molecule active

    1 trial

  5. Realgar-Indigo naturalis formula

    First Tracks Biotherapeutics

    Acute Promyelocytic Leukemia

    phase 3 small molecule active

    1 trial

  6. Recombinant Human Albumin Injection

    First Tracks Biotherapeutics

    Hepatic Ascites

    phase 3 mab completed

    2 trials

  7. Recombinant Human Thrombopoietin (rhTPO)

    First Tracks Biotherapeutics

    Immune Thrombocytopenia

    phase 3 small molecule completed

    1 trial

  8. Remdesivir

    First Tracks Biotherapeutics

    Covid19

    phase 3 small molecule active

    1 trial

  9. Remimazolam Besylate

    First Tracks Biotherapeutics

    Critical Illness; Mechanical Ventilation; Shock

    phase 3 small molecule active

    1 trial

  10. Rifaximin

    First Tracks Biotherapeutics

    Crohn Disease

    phase 3 small molecule active

    1 trial

  11. Rituximab

    First Tracks Biotherapeutics

    Diffuse Large B-cell Lymphoma

    phase 3 small molecule active

    3 trials

  12. Rituximab

    First Tracks Biotherapeutics

    Refractory Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  13. Robotic Gastrectomy

    First Tracks Biotherapeutics

    Gastric Cancer (GC)

    phase 3 other active

    1 trial

  14. S-1 therapy

    First Tracks Biotherapeutics

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule active

    1 trial

  15. Sorafenib

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia

    phase 3 small molecule completed

    1 trial

  16. Standard First-Line Therapy

    China SXT Pharmaceuticals

    Unresectable Colorectal Cancer

    phase 3 small molecule active

    1 trial

  17. Suxiao Jiuxin Pill

    First Tracks Biotherapeutics

    Acute Mountain Sickness

    phase 3 small molecule active

    1 trial

  18. TNK-tPA

    First Tracks Biotherapeutics

    Acute Ischemic Stroke

    phase 3 small molecule active

    1 trial

  19. Tecentriq 1 200 mg concentrate for solution for infusion, CISPLATIN , CARBOPLATIN , BNT327, ETOPOSIDE

    BioNTech Manufacturing GmbH

    English First-line extensive-stage small-cell lung cancer (ES-SCLC)

    phase 3 small molecule active

    1 trial

  20. The methylprednisolone sodium succinate

    First Tracks Biotherapeutics

    Acute Ischemic Stroke

    phase 3 small molecule active

    1 trial

  21. The placebo product consists of a soft capsule similar to the ones containing the active substance, VESSEL® 250 ULS capsule molli

    Fondazione Telethon ETS

    Prevention of recurrence after a first episode of Venous Thromboembolism (VTE)

    phase 3 small molecule active

    1 trial

  22. Tiaoshen Anti-cancer Granules

    First Tracks Biotherapeutics

    Ovarian Neoplasms Malignant

    phase 3 small molecule active

    1 trial

  23. Tinidazole oral microneedle patch

    First Tracks Biotherapeutics

    Evaluate the DFS of Patients With Esophageal Cancer Who Underwent Radical Operation After Regular Removal of Porphyromonas Gingivalis

    phase 3 other active

    1 trial

  24. Tislelizumab

    First Tracks Biotherapeutics

    Rectal Neoplasms

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources